Prevalent Dominant Acinetobacter baumannii ST191/195/208 Strains in Bloodstream Infections Have High Drug Resistance and Mortality

References

• Decker BK. Too much too soon or too little too late: the challenge of preventing acinetobacter transmissions. Crit Care Med. 2017;45(7):1252–1253. doi:10.1097/CCM.0000000000002418
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Dimopoulos G, Poulakou G, et al. European society of intensive care medicine. task force on management and prevention of acinetobacter baumannii infections in the ICU. Intensive Care Med. 2015;41(12):2057–2075. doi:10.1007/s00134-015-4079-4
   PubMed Web of Science ®Google Scholar
• Chen YB, Ji JR, Ying CQ, et al. BRICS report of 2020: the bacterial composition and antimicrobial resistance profile of clinical isolates from bloodstream infections in China. Chin J Clin Infect Dis. 2021;14(06):413–426. doi:10.3760/cma.j.issn.1674-2397.2021.06.002
   Google Scholar
• Onorato L, Macera M, Calò F, et al. The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis. Clin Microbiol Infect. 2020;26(6):782.e1–782.e6. doi:10.1016/j.cmi.2019.10.021
   PubMed Web of Science ®Google Scholar
• Giammanco A, Calà C, Fasciana T, Dowzicky MJ. Global assessment of the activity of Tigecycline against multidrug-resistant gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial. mSphere. 2017;2(1):e00310–16. doi:10.1128/mSphere.00310-16
   PubMed Web of Science ®Google Scholar
• Nutman A, Glick R, Temkin E, et al. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia. Clin Microbiol Infect. 2014;20(12):O1028–1034. doi:10.1111/1469-0691.12716
   PubMed Web of Science ®Google Scholar
• Niu T, Xiao T, Guo L, et al. Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality. Infect Drug Resist. 2018;26(11):2021–2030. doi:10.2147/IDR.S169432
   Google Scholar
• Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543(7643):15. doi:10.1038/nature.2017.21550
   PubMed Web of Science ®Google Scholar
• Jacobs AC, Thompson MG, Black CC, et al. AB5075, a highly virulent isolate of acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. MBio. 2014;5(3):e01076–14. doi:10.1128/mBio.01076-14
   PubMed Web of Science ®Google Scholar
• Ou HY, Kuang SN, He XY, et al. Complete genome sequence of hypervirulent and outbreak-associated acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors. Sci Rep. 2015;5:8643. doi:10.1038/srep08643
   PubMed Web of Science ®Google Scholar
• Karah N, Sundsfjord A, Towner K, Samuelsen Ø. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat. 2012;15(4):237–247. doi:10.1016/j.drup.2012.06.001
   PubMed Web of Science ®Google Scholar
• Jiang LL, Liang YC, Yao W, Ai JT, Wang X, Zhao ZG. Molecular epidemiology and genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates from Guangdong Province, South China. J Glob Antimicrob Resist. 2019;17:84–89. doi:10.1016/j.jgar.2018.11.002
   PubMed Web of Science ®Google Scholar
• Jiang MJ, Liu LJ, Ma YH, et al. Molecular epidemiology of multi-drug resistant acinetobacter baumannii Isolated in Shandong, China. Front Microbiol. 2016;7:1687. doi:10.3389/fmicb.2016.01687
   PubMed Web of Science ®Google Scholar
• Ning NZ, Liu X, Bao CM, et al. Molecular epidemiology of blaOXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China. BMC Infect Dis. 2017;17:14. doi:10.1186/s12879-016-2110-1
   PubMed Web of Science ®Google Scholar
• Chen T, Fu Y, Hua X, et al. Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infections. Int J Antimicrob Agents. 2021;58(4):106404. doi:10.1016/j.ijantimicag.2021.106404
   PubMed Web of Science ®Google Scholar
• Boo TW, Walsh F, Crowley B. First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic. J Antimicrob Chemother. 2006;58:1101–1102. doi:10.1093/jac/dkl345
   PubMed Web of Science ®Google Scholar
• Ruan Z, Chen Y, Jiang Y, et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents. 2013;42(4):322–328. doi:10.1016/j.ijantimicag.2013.06.019
   PubMed Web of Science ®Google Scholar
• Lv W, Zhang X, Hou M, Han D, Li Y, Xiong W. Draft genome sequence of an OXA-23, OXA-66, ADC-25 and TEM-1D co-producing Acinetobacter baumannii ST195 isolated from a patient with neonatal pneumonia in China. J Glob Antimicrob Resist. 2019;16:1–3. doi:10.1016/j.jgar.2018.11.008
   PubMed Web of Science ®Google Scholar
• Lean SS, Yeo CC, Suhaili Z, Thong KL. Whole-genome analysis of an extensively drug-resistant clinical isolate of Acinetobacter baumannii AC12: insights into the mechanisms of resistance of an ST195 clone from Malaysia. Int J Antimicrob Agents. 2015;45(2):178–182. doi:10.1016/j.ijantimicag.2014.10.015
   PubMed Web of Science ®Google Scholar
• Yoon EJ, Kim JO, Yang JW, et al. The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother. 2017;72(10):2708–2714. doi:10.1093/jac/dkx205
   PubMed Web of Science ®Google Scholar
• Hu L, Shi Y, Xu Q, et al. Capsule thickness, not biofilm formation, gives rise to mucoid acinetobacter baumannii phenotypes that are more prevalent in long-term infections: a study of clinical isolates from a hospital in China. Infect Drug Resist. 2020;13:99–109. doi:10.2147/IDR.S230178
   PubMed Web of Science ®Google Scholar
• Zhou K, Tang X, Wang L, et al. An Emerging Clone (ST457) of Acinetobacter baumannii clonal complex 92 with enhanced virulence and increasing endemicity in South China. Clin Infect Dis. 2018;67(S2):S179–S188. doi:10.1093/cid/ciy691
   PubMedGoogle Scholar
• Li YJ, Pan CZ, Fang CQ, et al. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality. BMC Infect Dis. 2017;17(1):371. doi:10.1186/s12879-017-2471-0
   PubMedGoogle Scholar
• Yang S, Sun J, Wu X, Zhang L. Determinants of mortality in patients with nosocomial acinetobacter baumannii bacteremia in Southwest China: a five-year case-control study. Can J Infect Dis Med Microbiol. 2018;2018:3150965. doi:10.1155/2018/3150965
   PubMed Web of Science ®Google Scholar
• Brotfain E, Borer A, Koyfman L, et al. Multidrug resistance acinetobacter bacteremia secondary to ventilator-associated pneumonia: risk factors and outcome. J Intensive Care Med. 2017;32(9):528–534. doi:10.1177/0885066616632193
   PubMed Web of Science ®Google Scholar
• Qu JY, Yu RJ, Wang QJ, Feng CL, Lv XJ. Synergistic antibacterial activity of combined antimicrobials and the clinical outcome of patients with carbapenemase-producing acinetobacter baumannii infection. Front Microbiol. 2020;11:541423. doi:10.3389/fmicb.2020.541423
   PubMed Web of Science ®Google Scholar
• Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16(2):91–102. doi:10.1038/nrmicro.2017.148
   PubMed Web of Science ®Google Scholar
• Casella LG, Weiss A, Pérez-Rueda E, Antonio Ibarra J, Shaw LN. Towards the complete proteinaceous regulome of acinetobacter baumannii. Microb Genom. 2017;3(3):mgen000107. doi:10.1099/mgen.0.000107
   PubMed Web of Science ®Google Scholar
• Bian X, Liu X, Zhang X, et al. Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics. BMC Genomics. 2021;22(1):530. doi:10.1186/s12864-021-07842-5
   PubMed Web of Science ®Google Scholar
• Ali HM, Salem MZM, El-Shikh MS, Megeed AA, Alogaibi YA, Talea IA. Investigation of the virulence factors and molecular characterization of the clonal relations of multidrug-resistant acinetobacter baumannii isolates. J AOAC Int. 2017;100(1):152–158. doi:10.5740/jaoacint.16-0139
   PubMed Web of Science ®Google Scholar